Update on the hospital management of community-acquired pneumonia in adults

Authors

Keywords:

PNEUMONIA, HOSPITAL MANAGEMENT, RESPIRATORY INFECTIONS.

Abstract

Introduction: pneumonia is an infectious and inflammatory process of the lung parenchyma caused by microorganisms that affect the distal portion of the respiratory tract.

Objective: to characterize the hospital management of community-acquired pneumonia.

Methods: a systematic bibliographic review was carried out in scientific databases such as: ELSEVIER, Clinical Key, Scielo, Scopus, PubMed, ACIMED and LATINDEX using articles between 2018 and 2024.

Results: different complementary diagnostic techniques for pneumonia are evident, such as PCR, specific biomarkers such as leukocyte count, blood cultures, with Gram staining being one of the easiest and fastest tests. Streptococcus pneumoniae is considered the most common infectious agent, followed by Haemophilus influenzae, and its classification is according to scales that evaluate various clinical characteristics. Antibiotic treatment of CAP will most often begin empirically based on knowledge of the prevalent microorganisms.

Conclusions: community-acquired pneumonia is a serious disease and is among the main causes of mortality worldwide, pneumonia prognostic scales allow discerning outpatient, hospital or intensive management of patients. Complementary studies that help identify the causal germ are important and allow guided treatment to be offered to patients. Prevention is an important point and it has three pillars; influenza vaccination, smoking cessation and pneumococcal vaccination in certain patients.

Downloads

Download data is not yet available.

References

1. Miravitlles M. Actualización de las recomendaciones ALAT sobre la neumonía adquirida en la comunidad. Sciencedirect [Internet]. 2018 [citado 23/12/2023]. 40(8):364–74. Disponible en: https://www.sciencedirect.com/science/article/pii/S0300289604755465

2. Irizar Aramburu MI, Arrondo Beguiristain MA, Insausti Carretero MJ, Mujica Campos J, Etxabarri Perez P, Ganzarain Gorosabel R. Epidemiología de la neumonía adquirida en la comunidad. Aten Primaria [Internet]. 2019 Dec [citado 23/12/2023];45(10):503–13. Disponible en: https://www.redalyc.org/journal/1702/170263334001/html/

3. López J. Neumonía adquirida en la comunidad y principales métodos de predicción de severidad. Redalyc. [Internet]. 2018 [citado 23/12/2023];13. Disponible en: https://www.redalyc.org/journal/1702/170263334001/html/

4. Martínez Vernaza S, Soto Chavez MJ, Mckinley E, Gualtero Trujillo S. Neumonía adquirida en la comunidad: una revisión narrativa. [Internet]. 2018 [citado 23/12/2023]. 59(4):1–10. Disponible en: http://www.scielo.org.co/scielo.php?pid=S2011-08392018000400093&script=sci_arttext

5. Hincapié C, Ascuntar J, León A, Jaimes F. Validation and comparison of three mortality prediction scores in emergency department patients with community-acquired pneumonia. [Internet]. 2021 [citado 23/12/2023]. 52(4). Disponible en: http://www.scielo.org.co/scielo.php?pid=S1657-95342021000404287&script=sci_arttext

6. Julián-Jiménez A, Adán Valero I, Beteta López A, Cano Martín LM, Fernández Rodríguez O, Rubio Díaz R, et al. Recommendations for the care of patients with community-acquired pneumonia in the Emergency Department. Euroe PMC [Internet]. 2018 [citado 23/12/2023]. 31(2):186–202. Disponible en: https://europepmc.org/article/pmc/6159381

7. Saldías-Peñafiel F, Salinas-Rossel G, Farcas-Oksenberg K, Reyes-Sánchez A, Díaz-Patiño O. Utilidad de la proteína C reactiva sérica en el diagnóstico y tratamiento del adulto inmunocompetente hospitalizado por neumonía adquirida en la comunidad. [Internet]. 2019 [citado 23/12/2023]. 147(8):983–92. Disponible en: https://www.scielo.cl/scielo.php?pid=S0034-98872019000800983&script=sci_arttext&tlng=pt

8. Menéndez R, España PP, Almirall J, Mendez R et al. Neumonía adquirida en la comunidad. Normativa de la Sociedad Española de Neumología y Cirugía Torácica (SEPAR). [Internet]. 2020 [citado 23/12/2023]. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S0300289620300405

9. Cortés JA. Guía de práctica clínica para el manejo de la neumonía adquirida en la comunidad. Dialnet [Internet]. 2022 [citado 23/12/2023]. Disponible en: https://dialnet.unirioja.es/servlet/articulo?codigo=8801418

10. Castillo JG, Julián Jiménez A, Javier Candel F. Neumonía comunitaria: selección del tratamiento empírico y terapia secuencial. Implicaciones del SARS-CoV-2. PubMed [Internet]. 2021 [citado 23/12/2023]. 34.6 (2021): 599. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8638761/

11. Metlay Joshua P, Waterer GW, Anzueto A, Brozek J et al. Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. [Internet]. 2019 [citado 23/12/2023]. Disponible en: https://www.atsjournals.org/doi/full/10.1164/rccm.201908-1581ST

12. Berastegui-Cabrera J. Neumonía adquirida en la comunidad de etiología viral: diversidad, especificidad diagnóstica y factores pronósticos. Dialnet [Internet]. 2022 [citado 23/12/2023]. Disponible en: https://dialnet.unirioja.es/servlet/dctes?codigo=307557

13. Berrera M, Lozada C, Chacin AM, Chirinos M, Albers AJ. Neumonía adquirida en la comunidad mediante las escalas PSI y CURB-65. [Internet]. 2022 [citado 23/12/2023]. Disponible en: http://servicio.bc.uc.edu.ve/fcs/vol26n1/art03.pdf

14. Herrera-Bandek ME, Obando-Estrada S, Porras-Umaña T. Neumonía adquirida en la comunidad: diagnóstico y tratamiento. UACA [Internet]. 2022 [citado 23/12/2023]. 149-166.Disponible en: http://encuestas.uaca.ac.cr/index.php/actas/article/view/1342

15. Dopico-Ravelo D. Hemocultivo como medio para establecer el mapa microbiológico en la neumonía adquirida en la comunidad. Rev de Cien Med de Pinar del Rio [Internet]. 2022 [citado 23/12/2023]. 26.6. Disponible en: http://scielo.sld.cu/scielo.php?pid=S1561-31942022000600008&script=sci_arttext

16. Vélez L, Marcela A. Validación de la puntuación curb 65 en la predicción de gravedad en pacientes con neumonía extrahospitalaria. Univ de Gaya [Internet]. 2022 [citado 23/12/2023]. 26.6. Disponible en: https://repositorio.ug.edu.ec/items/7570089e-4ebc-4592-9629-4b6038f8ada1

17. Cemeli Cano M. Características clínicas y evolutivas de la neumonía adquirida en la comunidad en pacientes hospitalarios. [Internet]. 2020 [citado 23/12/2023] 22 (85). Disponible en: https://scielo.isciii.es/scielo.php?pid=S1139-76322020000100005&script=sci_arttext&tlng=pt

18. Puchaicela MA. Neumonía adquirida en la comunidad: Valoración inicial y aplicación de escalas de evaluación clínica. [Internet]. 2019 [citado 23/12/2023] 29-38. Disponible en: https://revistaacademica-istcre.edu.ec/storage/publicaciones/revista/Junio%202019%20Vol.%203%20Nro.%201/articulo/pdf/ARTICULO3.pdf

19. Sánchez Agüero AC, Rivera Fumero S, Salas Garita F. Abordaje actualizado sobre la neumonía adquirida en la comunidad en adultos. Rev Cienc y Salud [Internet]. 2020 [citado 23/12/2023] Disponible en: https://revistacienciaysalud.ac.cr/ojs/index.php/cienciaysalud/article/view/148

20. Saldías F. Características radiográficas de la neumonía adquirida en la comunidad en el adulto inmunocompetente hospitalizado según el agente causal. Rev Chil de Enfer Resp [Internet]. 2022 [citado 23/12/2023] 38.2. Disponible en: https://www.scielo.cl/scielo.php?pid=S0717-73482022000200096&script=sci_arttext&tlng=en

Downloads

Published

2023-12-31

How to Cite

1.
León-Pallasco DA, Cobo-Álvarez DA, Robles-Abarca SG, Orozco-Herrera JF. Update on the hospital management of community-acquired pneumonia in adults. Rev Ciencias Médicas [Internet]. 2023 Dec. 31 [cited 2025 Oct. 13];27(2):e6298. Available from: https://revcmpinar.sld.cu/index.php/publicaciones/article/view/6298

Issue

Vol. 27 No. 2 (2023): Supplement 2: International Scientific Congress on Research and Development UNIANDES Ibarra-Tulcán 2023

Section

REVIEW ARTICLES

License

Authors who have publications with this journal agree to the following terms: Authors will retain their copyrights and grant the journal the right of first publication of their work, which will be publication of their work, which will be simultaneously subject to the Creative Commons Attribution License (CC-BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.

Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g.: deposit it in an institutional telematic archive or publish it in a volume). Likewise, and according to the recommendations of the Medical Sciences Editorial (ECIMED), authors must declare in each article their contribution according to the CRediT taxonomy (contributor roles). This taxonomy includes 14 roles, which can be used to represent the tasks typically performed by contributors in scientific academic production. It should be consulted in monograph) whenever initial publication in this journal is indicated. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which may produce interesting exchanges and increase citations of the published work. (See The effect of open access). https://casrai.org/credit/